Molecular Medicine · 2007 · 261 citations · 20 references
Life SciencesCardiologyPhysiologyImmunophysiologyInflammationInnate ImmunityCardiac PhysiologyCardiovascular DiseaseCardiovascular PathophysiologyCardiovascular PhysiologyCytokine BiologyHeart Rate VariabilityCardiac Vagal ControlCardiac Vagal ToneHeart Rate Variability IndicesHeart Rate Variability MeasurementImmune MarkersInflammatory Cardiac BiomarkersVagal ModulationVagus Nerve Anti-inflammatory Pathway
Recent evidence reveals that the immune system is under the direct control of the vagus nerve via the "cholinergic anti-inflammatory pathway." Stimulation of vagus nerve activity significantly inhibits cytokine levels in animal models, and cholinergic agents inhibit cytokine release by human macrophages. Moreover, when vagus nerve activity is decreased or absent, cytokines are overproduced. Atherosclerosis is an inflammatory disease characterized by elevated levels of CRP and IL-6, but the relationship between cardiac vagal activity and cytokine levels in healthy humans is not well understood. Here we measured RR interval variability, an index of cardiac vagal modulation, and CRP and IL-6 in 757 subjects participating in a subset of the year 15 data collection in the CARDIA study of the evolution of risk factors in young adults. Univariate analysis revealed that all indices of RRV were strongly and inversely related to IL-6 (log pg/mL b=-0.08 and -0.17 for HF and LF power, P<0.001 respectively) and CRP (log mg/L b=-0.14 and -0.26 for HF and LF power, P<0.001 respectively) levels. In the multivariate model including gender, race, age, smoking, physical activity, SBP, BMI, and disease, the inverse relationship between RRV and inflammatory markers, although slightly attenuated, remained significant. These findings are consistent with the hypothesis that diminished descending vagal anti-inflammatory signals can allow cytokine overproduction in humans.
20
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Hong Wang, Hong Liao, Mahendar Ochani et al. · Nature Medicine · 2004 · 1.2K citations
Mechanisms Underlying Very-Low-Frequency RR-Interval Oscillations in Humans
J. Andrew Taylor, Deborah L. Carr, Christopher W. Myers et al. · Circulation · 1998 · 655 citations · Full text
Medicine, Cardiology, Pharmacology +15
Reduced Heart Rate Variability and New-Onset Hypertension
Jagmeet P. Singh, Martin G. Larson, Hisako Tsuji et al. · Hypertension · 1998 · 559 citations · Full text
Medicine, Cardiology, Physiology +17